PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 14, 2026JAMA Ophthalmology0 citations

Age and Genetic Testing Refine Conversion Risk in Unilateral Retinoblastoma

Bilateral Conversion Risk in Unilateral Retinoblastoma Using Age and Genetic Testing

View Full Paper
Ask AI
Bookmark
Share

Authors

EDErkuan DaiHXHaodong XiaoRZRulian Zhao

Discussion

Loading...

Member takes

Overview

Findings demonstrate lower conversion risk for older RB1 variant-positive patients, suggesting tailored monitoring strategies.

Key Points

  • To explore how age and genetic testing inform the risk of bilateral conversion in unilateral retinoblastoma.
  • Analyzed age at diagnosis and genetic testing outcomes for unilateral retinoblastoma patients.
  • Identified subgroups based on RB1 variant status.
  • Assessed implications for surveillance and risk stratification.
  • RB1 variant-positive patients diagnosed after 9 months are low-risk for bilateral conversion.
  • Late conversions observed in RB1 variant-negative patients require ongoing monitoring.
  • Risk stratification can be enhanced using age-related data.

Cite This Study

Dai et al. (2026) studied this question.

synapsesocial.com/papers/69b4b9fb18185d8a39802504https://doi.org/10.1001/jamaophthalmol.2026.0143
View Full Paper
Ask AI
Bookmark
Share